ArticleMolecular therapy. Nucleic acids2019
CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model.
Freja K Ekman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this papercites it